Quidel Stock Price, News & Analysis (NASDAQ:QDEL)

$40.17 0.16 (0.40 %)
(As of 12/14/2017 10:10 AM ET)
Previous Close$40.01
Today's Range$39.68 - $40.27
52-Week Range$18.25 - $45.55
Volume230,400 shs
Average Volume298,459 shs
Market Capitalization$1.36 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.15

About Quidel (NASDAQ:QDEL)

Quidel logoQuidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions are separated into four product categories: immunoassays, molecular assays, virology and specialty products. The Company sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics, pharmacies and wellness screening centers. Its diagnostic solutions aid in the detection and diagnosis of critical diseases and other medical conditions, including infectious diseases, women's health, gastrointestinal diseases, autoimmune diseases, bone health and thyroid diseases. The Company provides diagnostic testing solutions under various brand names, including Quidel, QuickVue, QuickVue+, MicroVue, FreshCells, D3 FastPoint, Super E-Mix, ELVIS, Sofia, Quidel Molecular, Amplivue, Lyra and Thyretain.

Receive QDEL News and Ratings via Email

Sign-up to receive the latest news and ratings for QDEL and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Advanced Medical Equipment & Technology
Sub-IndustryHealth Care Supplies
SectorMedical
SymbolNASDAQ:QDEL
CUSIP74838J10
Phone858-552-1100

Debt

Debt-to-Equity Ratio0.70%
Current Ratio6.28%
Quick Ratio5.68%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E Ratio66.95
P/E Growth2.65

Sales & Book Value

Annual Sales$191.60 million
Price / Sales7.13
Cash Flow$0.46 per share
Price / Cash87.83
Book Value$6.15 per share
Price / Book6.53

Profitability

Trailing EPS($0.15)
Net Income$-13,800,000.00
Net Margins-2.33%
Return on Equity-2.36%
Return on Assets-1.25%

Miscellaneous

Employees627
Outstanding Shares34,000,000

Quidel (NASDAQ:QDEL) Frequently Asked Questions

What is Quidel's stock symbol?

Quidel trades on the NASDAQ under the ticker symbol "QDEL."

How were Quidel's earnings last quarter?

Quidel Corporation (NASDAQ:QDEL) released its quarterly earnings results on Wednesday, November, 1st. The company reported ($0.16) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $0.05 by $0.21. The firm had revenue of $50.89 million for the quarter, compared to analyst estimates of $50.47 million. Quidel had a negative net margin of 2.33% and a negative return on equity of 2.36%. The firm's revenue was up 3.1% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.10 EPS. View Quidel's Earnings History.

When will Quidel make its next earnings announcement?

Quidel is scheduled to release their next quarterly earnings announcement on Wednesday, February, 14th 2018. View Earnings Estimates for Quidel.

Where is Quidel's stock going? Where will Quidel's stock price be in 2017?

6 Wall Street analysts have issued twelve-month price targets for Quidel's stock. Their forecasts range from $47.00 to $50.00. On average, they anticipate Quidel's stock price to reach $48.50 in the next twelve months. View Analyst Ratings for Quidel.

Who are some of Quidel's key competitors?

Who are Quidel's key executives?

Quidel's management team includes the folowing people:

  • Kenneth F. Buechler Ph.D., Chairman of the Board (Age 63)
  • Douglas C. Bryant, President, Chief Executive Officer, Director (Age 59)
  • Randall J. Steward, Chief Financial Officer (Age 62)
  • Robert Joseph Bujarski J.D., Senior Vice President - Business Development, General Counsel and Corporate Secretary (Age 48)
  • Michael D. Abney Jr., Senior Vice President - Distribution (Age 81)
  • Werner Kroll Ph.D, Senior Vice President,R&D (Age 60)
  • Edward Keith Russell, Senior Vice President - Global Commercial Operations (Age 49)
  • Thomas D. Brown, Independent Director (Age 69)
  • Mary Lake Polan M.D. Ph.D., Independent Director (Age 73)
  • Jack W. Schuler, Independent Director (Age 76)

Who owns Quidel stock?

Quidel's stock is owned by a number of of institutional and retail investors. Top institutional investors include Macquarie Group Ltd. (2.95%), New York State Common Retirement Fund (2.65%), Dimensional Fund Advisors LP (2.49%), Gabelli Funds LLC (1.93%), Gamco Investors INC. ET AL (1.70%) and Cannell Peter B & Co. Inc. (1.20%). Company insiders that own Quidel stock include Douglas C Bryant, John Tamerius, Michael Donald Jr Abney, Randall J Steward, Ratan S Borkar, Robert Joseph Bujarski, Thomas D Brown and Werner Kroll. View Institutional Ownership Trends for Quidel.

Who sold Quidel stock? Who is selling Quidel stock?

Quidel's stock was sold by a variety of institutional investors in the last quarter, including Macquarie Group Ltd., Chicago Equity Partners LLC, Investment Management of Virginia LLC, Cannell Peter B & Co. Inc., Gamco Investors INC. ET AL, Gabelli Funds LLC, Dupont Capital Management Corp and Trellus Management Company LLC. Company insiders that have sold Quidel company stock in the last year include Douglas C Bryant, Michael Donald Jr Abney, Randall J Steward, Ratan S Borkar, Robert Joseph Bujarski, Thomas D Brown and Werner Kroll. View Insider Buying and Selling for Quidel.

Who bought Quidel stock? Who is buying Quidel stock?

Quidel's stock was bought by a variety of institutional investors in the last quarter, including Davidson Kempner Capital Management LP, Omni Partners LLP, Columbus Circle Investors, EAM Investors LLC, Ameriprise Financial Inc., TD Asset Management Inc., Wells Fargo & Company MN and Smith Asset Management Group LP. View Insider Buying and Selling for Quidel.

How do I buy Quidel stock?

Shares of Quidel can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Quidel's stock price today?

One share of Quidel stock can currently be purchased for approximately $40.17.

How big of a company is Quidel?

Quidel has a market capitalization of $1.36 billion and generates $191.60 million in revenue each year. The company earns $-13,800,000.00 in net income (profit) each year or ($0.15) on an earnings per share basis. Quidel employs 627 workers across the globe.

How can I contact Quidel?

Quidel's mailing address is 12544 HIGH BLUFF DRIVE SUITE 200, SAN DIEGO CA, 92130. The company can be reached via phone at 858-552-1100 or via email at [email protected]


MarketBeat Community Rating for Quidel (QDEL)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  187 (Vote Outperform)
Underperform Votes:  196 (Vote Underperform)
Total Votes:  383
MarketBeat's community ratings are surveys of what our community members think about Quidel and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Quidel (NASDAQ:QDEL) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyHold
Consensus Rating Score: 2.832.832.672.29
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $48.50$48.50$31.75$22.30
Price Target Upside: 24.20% upside24.20% upside11.90% downside7.28% downside

Quidel (NASDAQ:QDEL) Consensus Price Target History

Price Target History for Quidel (NASDAQ:QDEL)

Quidel (NASDAQ:QDEL) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/3/2017Piper Jaffray CompaniesReiterated RatingBuy$50.00N/AView Rating Details
11/2/2017BarclaysBoost Price TargetOverweight$45.00 -> $49.00N/AView Rating Details
10/25/2017Canaccord GenuityReiterated RatingBuy$48.00N/AView Rating Details
9/19/2017Raymond James FinancialReiterated RatingBuy$41.00 -> $47.00HighView Rating Details
7/18/2017William BlairUpgradeMarket Perform -> OutperformHighView Rating Details
2/17/2017CL KingInitiated CoverageNeutralN/AView Rating Details
2/18/2016Craig HallumLower Price TargetHold$18.00 -> $16.00N/AView Rating Details
(Data available from 12/14/2015 forward)

Earnings

Quidel (NASDAQ:QDEL) Earnings History and Estimates Chart

Earnings by Quarter for Quidel (NASDAQ:QDEL)

Quidel (NASDAQ QDEL) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/6/2018N/AView Earnings Details
11/1/2017Q3 2017$0.05($0.16)$50.47 million$50.89 millionViewN/AView Earnings Details
7/26/2017Q2 2017($0.17)($0.35)$41.91 million$38.30 millionViewN/AView Earnings Details
4/24/2017Q1 2017$0.15$0.45$61.85 million$73.70 millionViewN/AView Earnings Details
2/8/2017Q416$0.02$0.17$58.42 million$52.80 millionViewListenView Earnings Details
10/26/2016Q316($0.02)$0.10$50.88 million$49.30 millionViewListenView Earnings Details
7/27/2016Q216($0.25)($0.11)$37.98 million$39.10 millionViewListenView Earnings Details
4/27/2016Q116($0.07)$0.02$49.21 million$50.30 millionViewListenView Earnings Details
2/17/2016Q415$0.05$0.10$54.01 million$52.40 millionViewListenView Earnings Details
10/28/2015Q315($0.14)$0.05$43.48 million$46.80 millionViewListenView Earnings Details
7/22/2015Q215($0.25)($0.14)$34.17 million$34.87 millionViewListenView Earnings Details
4/23/2015Q115$0.12$0.30$61.22 million$61.30 millionViewListenView Earnings Details
2/11/2015Q414$0.10$0.37$60.61 million$63.60 millionViewListenView Earnings Details
10/21/2014Q314($0.12)($0.01)$37.80 million$40.90 millionViewListenView Earnings Details
7/22/2014Q214($0.16)($0.10)$31.90 million$31.50 millionViewListenView Earnings Details
4/23/2014Q114$0.30$0.08$63.26 million$46.70 millionViewListenView Earnings Details
2/11/2014Q413$0.09$0.20$48.67 million$50.00 millionViewListenView Earnings Details
10/23/2013Q313($0.07)($0.02)$37.32 million$33.50 millionViewListenView Earnings Details
7/30/2013Q2 2013($0.11)($0.06)$33.24 million$29.71 millionViewListenView Earnings Details
4/23/2013Q1 2013$0.46$0.49$62.63 million$61.99 millionViewN/AView Earnings Details
2/12/2013Q4 2012$0.29$0.26$53.30 million$53.93 millionViewListenView Earnings Details
10/23/2012($0.03)$0.08ViewN/AView Earnings Details
7/25/2012($0.08)$0.01ViewN/AView Earnings Details
2/29/2012$0.06$0.15ViewN/AView Earnings Details
10/25/2011($0.06)($0.03)ViewN/AView Earnings Details
8/2/2011($0.07)($0.04)ViewN/AView Earnings Details
4/28/2011$0.33$0.35ViewN/AView Earnings Details
2/24/2011($0.01)$0.02ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Quidel (NASDAQ:QDEL) Earnings Estimates

2017 EPS Consensus Estimate: $0.26
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q4 20171$0.26$0.26$0.26
Q1 20181$0.34$0.34$0.34
Q2 20181($0.08)($0.08)($0.08)
Q4 20181$0.34$0.34$0.34
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Quidel (NASDAQ:QDEL)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Quidel (NASDAQ QDEL) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 22.00%
Institutional Ownership Percentage: 92.67%
Insider Trades by Quarter for Quidel (NASDAQ:QDEL)
Institutional Ownership by Quarter for Quidel (NASDAQ:QDEL)

Quidel (NASDAQ QDEL) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/8/2017Werner KrollSVPSell16,358$40.44$661,517.52View SEC Filing  
12/5/2017Thomas D BrownDirectorSell12,154$39.62$481,541.48View SEC Filing  
12/4/2017Ratan S BorkarSVPSell24,781$40.05$992,479.05View SEC Filing  
11/30/2017Douglas C BryantCEOSell36,000$37.36$1,344,960.00View SEC Filing  
11/28/2017Douglas C BryantCEOSell12,000$36.72$440,640.00View SEC Filing  
11/9/2017Ratan S BorkarSVPSell7,965$38.91$309,918.15View SEC Filing  
11/6/2017Werner KrollSVPSell7,565$39.50$298,817.50View SEC Filing  
10/30/2017Douglas C BryantCEOSell12,000$41.15$493,800.00View SEC Filing  
10/27/2017Douglas C BryantCEOSell12,000$42.29$507,480.00View SEC Filing  
9/29/2017Douglas C BryantCEOSell36,000$42.91$1,544,760.00View SEC Filing  
9/28/2017Douglas C BryantCEOSell12,000$42.86$514,320.00View SEC Filing  
9/27/2017Douglas C BryantCEOSell12,000$42.17$506,040.00View SEC Filing  
8/31/2017Douglas C BryantCEOSell36,000$34.44$1,239,840.00View SEC Filing  
7/31/2017Douglas C BryantCEOSell36,000$33.83$1,217,880.00View SEC Filing  
7/28/2017Michael Donald Jr. AbneySVPSell1,173$33.83$39,682.59View SEC Filing  
7/28/2017Randall J StewardCFOSell94,215$34.09$3,211,789.35View SEC Filing  
6/30/2017Douglas C BryantCEOSell36,000$27.30$982,800.00View SEC Filing  
5/31/2017Douglas C BryantCEOSell36,000$24.98$899,280.00View SEC Filing  
5/30/2017Douglas C BryantCEOSell12,000$25.10$301,200.00View SEC Filing  
5/26/2017Douglas C BryantCEOSell12,000$24.90$298,800.00View SEC Filing  
5/2/2017Robert Joseph BujarskiSVPSell43,225$24.27$1,049,070.75View SEC Filing  
5/1/2017Robert Joseph BujarskiSVPSell33,225$24.20$804,045.00View SEC Filing  
4/28/2017Douglas C BryantCEOSell36,000$24.16$869,760.00View SEC Filing  
3/31/2017Douglas C BryantCEOSell37,080$22.50$834,300.00View SEC Filing  
2/28/2017Douglas C. BryantCEOSell106,920$21.39$2,287,018.80View SEC Filing  
12/1/2016Robert Joseph BujarskiSVPSell60,000$22.84$1,370,400.00View SEC Filing  
11/30/2016Douglas C BryantCEOSell72,000$22.89$1,648,080.00View SEC Filing  
11/29/2016Douglas C BryantCEOSell24,000$22.84$548,160.00View SEC Filing  
11/28/2016Douglas C BryantCEOSell24,000$23.02$552,480.00View SEC Filing  
11/25/2016John TameriusSVPSell8,878$23.50$208,633.00View SEC Filing  
9/30/2016Douglas C BryantCEOSell69,168$21.76$1,505,095.68View SEC Filing  
8/30/2016Douglas C BryantCEOSell2,832$22.00$62,304.00View SEC Filing  
8/9/2016Robert Joseph BujarskiSVPSell22,057$22.58$498,047.06View SEC Filing  
8/1/2016John TameriusSVPSell7,000$23.02$161,140.00View SEC Filing  
2/19/2016Douglas C. BryantCEOBuy3,700$13.91$51,467.00View SEC Filing  
12/2/2015John TameriusSVPSell21,109$21.95$463,342.55View SEC Filing  
10/30/2015Douglas C BryantCEOBuy20,000$19.76$395,200.00View SEC Filing  
10/3/2014John TameriusSVPSell5,000$28.00$140,000.00View SEC Filing  
9/18/2014John TameriusSVPSell10,000$26.50$265,000.00View SEC Filing  
7/24/2014Douglas C BryantCEOBuy20,000$24.12$482,400.00View SEC Filing  
7/23/2014John TameriusSVPSell15,000$24.50$367,500.00View SEC Filing  
6/24/2014John TameriusSVPSell5,000$23.06$115,300.00View SEC Filing  
2/26/2014John TameriusSVPSell47,246$27.69$1,308,241.74View SEC Filing  
2/13/2014Rodney DammeyerDirectorSell26,000$27.70$720,200.00View SEC Filing  
10/29/2013Mark PulidoDirectorSell12,750$25.31$322,702.50View SEC Filing  
5/29/2013Robert Joseph BujarskiSVPSell28,808$23.16$667,193.28View SEC Filing  
5/17/2013Robert Joseph BujarskiSVPSell27,479$23.12$635,314.48View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Quidel (NASDAQ QDEL) News Headlines

Source:
DateHeadline
Zacks: Analysts Expect Quidel Corporation (QDEL) Will Post Quarterly Sales of $115.02 MillionZacks: Analysts Expect Quidel Corporation (QDEL) Will Post Quarterly Sales of $115.02 Million
www.americanbankingnews.com - December 13 at 2:50 AM
Insider Selling: Quidel Corporation (QDEL) SVP Sells 16,358 Shares of StockInsider Selling: Quidel Corporation (QDEL) SVP Sells 16,358 Shares of Stock
www.americanbankingnews.com - December 12 at 8:42 PM
$0.45 EPS Expected for Quidel Corporation (QDEL) This Quarter$0.45 EPS Expected for Quidel Corporation (QDEL) This Quarter
www.americanbankingnews.com - December 11 at 9:30 PM
Quidel Corp. breached its 50 day moving average in a Bullish Manner : QDEL-US : December 11, 2017Quidel Corp. breached its 50 day moving average in a Bullish Manner : QDEL-US : December 11, 2017
finance.yahoo.com - December 11 at 12:04 PM
Quidel Corporation (QDEL) Director Sells $481,541.48 in StockQuidel Corporation (QDEL) Director Sells $481,541.48 in Stock
www.americanbankingnews.com - December 7 at 9:04 PM
Insider Selling: Quidel Corporation (QDEL) SVP Sells 24,781 Shares of StockInsider Selling: Quidel Corporation (QDEL) SVP Sells 24,781 Shares of Stock
www.americanbankingnews.com - December 6 at 8:28 PM
Quidel Corporation (QDEL) Given Average Recommendation of "Buy" by BrokeragesQuidel Corporation (QDEL) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - December 4 at 5:36 AM
Quidel (QDEL) Upgraded to Hold at BidaskClubQuidel (QDEL) Upgraded to Hold at BidaskClub
www.americanbankingnews.com - December 2 at 11:54 AM
Dynatronics (DYNT) versus Quidel (QDEL) Head to Head SurveyDynatronics (DYNT) versus Quidel (QDEL) Head to Head Survey
www.americanbankingnews.com - December 2 at 7:24 AM
Douglas C. Bryant Sells 12,000 Shares of Quidel Corporation (QDEL) StockDouglas C. Bryant Sells 12,000 Shares of Quidel Corporation (QDEL) Stock
www.americanbankingnews.com - November 30 at 10:34 PM
Quidel Corporation (QDEL) CEO Sells $1,344,960.00 in StockQuidel Corporation (QDEL) CEO Sells $1,344,960.00 in Stock
www.americanbankingnews.com - November 30 at 10:34 PM
Quidel Corp (QDEL) Says its Confident in Legal Strength and Validity of Supply Agreement with Beckman Coulter to Sell BNP Assay AssetsQuidel Corp (QDEL) Says it's Confident in Legal Strength and Validity of Supply Agreement with Beckman Coulter to Sell BNP Assay Assets
www.streetinsider.com - November 28 at 3:37 PM
ETFs with exposure to Quidel Corp. : November 28, 2017ETFs with exposure to Quidel Corp. : November 28, 2017
finance.yahoo.com - November 28 at 3:37 PM
Společnost Beckman Coulter otevřela obchodní spor s firmou Quidel v souvislosti s přímým prodejem testů BNPSpolečnost Beckman Coulter otevřela obchodní spor s firmou Quidel v souvislosti s přímým prodejem testů BNP
www.prnewswire.com - November 28 at 5:28 AM
Beckman Coulter entabla disputa comercial con Quidel para vender BNP directamenteBeckman Coulter entabla disputa comercial con Quidel para vender BNP directamente
www.prnewswire.com - November 27 at 7:52 PM
Beckman Coulter entra em disputa comercial com a Quidel para vender BNP diretamenteBeckman Coulter entra em disputa comercial com a Quidel para vender BNP diretamente
www.prnewswire.com - November 27 at 7:52 PM
Why Quidel Corporation Is SinkingWhy Quidel Corporation Is Sinking
finance.yahoo.com - November 27 at 4:27 PM
Zacks: Brokerages Expect Quidel Corporation (QDEL) Will Post Quarterly Sales of $115.02 MillionZacks: Brokerages Expect Quidel Corporation (QDEL) Will Post Quarterly Sales of $115.02 Million
www.americanbankingnews.com - November 25 at 2:58 AM
Quidel to Present at the 29th Annual Piper Jaffray Healthcare ConferenceQuidel to Present at the 29th Annual Piper Jaffray Healthcare Conference
finance.yahoo.com - November 18 at 11:09 AM
Ratan S. Borkar Sells 7,965 Shares of Quidel Corporation (QDEL) StockRatan S. Borkar Sells 7,965 Shares of Quidel Corporation (QDEL) Stock
www.americanbankingnews.com - November 13 at 10:25 PM
ETFs with exposure to Quidel Corp. : November 8, 2017ETFs with exposure to Quidel Corp. : November 8, 2017
finance.yahoo.com - November 9 at 12:09 PM
Quidel Corporation (QDEL) Receives Average Recommendation of "Buy" from AnalystsQuidel Corporation (QDEL) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - November 9 at 6:30 AM
Quidel Corporation (QDEL) SVP Sells $298,817.50 in StockQuidel Corporation (QDEL) SVP Sells $298,817.50 in Stock
www.americanbankingnews.com - November 8 at 9:22 PM
Quidel Corporation (QDEL) Rating Lowered to Hold at Zacks Investment ResearchQuidel Corporation (QDEL) Rating Lowered to Hold at Zacks Investment Research
www.americanbankingnews.com - November 7 at 11:16 AM
Quidel Corp. – Value Analysis (NASDAQ:QDEL) : November 6, 2017Quidel Corp. – Value Analysis (NASDAQ:QDEL) : November 6, 2017
finance.yahoo.com - November 7 at 9:14 AM
Quidel Corp. :QDEL-US: Earnings Analysis: Q3, 2017 By the Numbers : November 7, 2017Quidel Corp. :QDEL-US: Earnings Analysis: Q3, 2017 By the Numbers : November 7, 2017
finance.yahoo.com - November 7 at 9:14 AM
Quidel Corporation (QDEL) Expected to Announce Quarterly Sales of $117.16 MillionQuidel Corporation (QDEL) Expected to Announce Quarterly Sales of $117.16 Million
www.americanbankingnews.com - November 6 at 2:30 AM
Zacks: Brokerages Expect Quidel Corporation (QDEL) to Announce $0.39 Earnings Per ShareZacks: Brokerages Expect Quidel Corporation (QDEL) to Announce $0.39 Earnings Per Share
www.americanbankingnews.com - November 4 at 7:22 PM
Quidel Becomes Oversold (QDEL)Quidel Becomes Oversold (QDEL)
www.nasdaq.com - November 4 at 10:11 AM
Quidel Corp. breached its 50 day moving average in a Bearish Manner : QDEL-US : November 3, 2017Quidel Corp. breached its 50 day moving average in a Bearish Manner : QDEL-US : November 3, 2017
finance.yahoo.com - November 4 at 10:11 AM
Piper Jaffray Companies Reaffirms "Buy" Rating for Quidel Corporation (QDEL)Piper Jaffray Companies Reaffirms "Buy" Rating for Quidel Corporation (QDEL)
www.americanbankingnews.com - November 3 at 10:46 PM
Barclays PLC Increases Quidel Corporation (QDEL) Price Target to $49.00Barclays PLC Increases Quidel Corporation (QDEL) Price Target to $49.00
www.americanbankingnews.com - November 2 at 7:42 PM
Quidel Reports Third Quarter 2017 Financial ResultsQuidel Reports Third Quarter 2017 Financial Results
finance.yahoo.com - November 2 at 8:02 AM
Edited Transcript of QDEL earnings conference call or presentation 1-Nov-17 9:00pm GMTEdited Transcript of QDEL earnings conference call or presentation 1-Nov-17 9:00pm GMT
finance.yahoo.com - November 2 at 8:02 AM
Quidel Corporation (QDEL) Releases  Earnings Results, Beats Expectations By $0.20 EPSQuidel Corporation (QDEL) Releases Earnings Results, Beats Expectations By $0.20 EPS
www.americanbankingnews.com - November 1 at 8:56 PM
Quidel Corporation (QDEL) CEO Douglas C. Bryant Sells 12,000 SharesQuidel Corporation (QDEL) CEO Douglas C. Bryant Sells 12,000 Shares
www.americanbankingnews.com - October 31 at 8:44 PM
Quidel Corporation (QDEL) Set to Announce Quarterly Earnings on WednesdayQuidel Corporation (QDEL) Set to Announce Quarterly Earnings on Wednesday
www.americanbankingnews.com - October 25 at 10:31 AM
Quidel Corp (QDEL) Receives FDA 510(k) Clearance for Its Point-of-Care Sofia Lyme FIAQuidel Corp (QDEL) Receives FDA 510(k) Clearance for Its Point-of-Care Sofia Lyme FIA
www.streetinsider.com - October 24 at 9:01 AM
Quidel Receives FDA Clearance for Its Point-of-Care Sofia® Lyme FIAQuidel Receives FDA Clearance for Its Point-of-Care Sofia® Lyme FIA
finance.yahoo.com - October 24 at 9:01 AM
Quidel Corporation (QDEL) Expected to Announce Quarterly Sales of $51.06 MillionQuidel Corporation (QDEL) Expected to Announce Quarterly Sales of $51.06 Million
www.americanbankingnews.com - October 18 at 3:10 PM
Quidel Receives FDA Clearance for Its Solana® RSV + hMPV AssayQuidel Receives FDA Clearance for Its Solana® RSV + hMPV Assay
finance.yahoo.com - October 17 at 4:23 PM
Quidel Corporation (QDEL) Receives Average Rating of "Buy" from BrokeragesQuidel Corporation (QDEL) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - October 15 at 7:56 AM
Zacks Investment Research Upgrades Quidel Corporation (QDEL) to "Buy"Zacks Investment Research Upgrades Quidel Corporation (QDEL) to "Buy"
www.americanbankingnews.com - October 14 at 12:12 PM
Quidel to Hold Third Quarter 2017 Financial Results Conference Call on November 1, 2017Quidel to Hold Third Quarter 2017 Financial Results Conference Call on November 1, 2017
finance.yahoo.com - October 14 at 7:06 AM
Quidel Announces Closing of Acquisition of Alere Triage® Assets Creating an Expanded Portfolio of Rapid Diagnostic Capabilities in Critical Care SettingsQuidel Announces Closing of Acquisition of Alere Triage® Assets Creating an Expanded Portfolio of Rapid Diagnostic Capabilities in Critical Care Settings
finance.yahoo.com - October 7 at 7:44 AM
Reviewing Quidel Corporation (QDEL) & GenMark Diagnostics (GNMK)Reviewing Quidel Corporation (QDEL) & GenMark Diagnostics (GNMK)
www.americanbankingnews.com - October 4 at 9:12 AM
Quidel Announces Early Termination of the Hart-Scott-Rodino Waiting Period for Its Pending Acquisition of Alere’s Triage® B-type Naturietic Peptide (BNP) Assay Business Run on Beckman Coulter AnalyzersQuidel Announces Early Termination of the Hart-Scott-Rodino Waiting Period for Its Pending Acquisition of Alere’s Triage® B-type Naturietic Peptide (BNP) Assay Business Run on Beckman Coulter Analyzers
finance.yahoo.com - October 3 at 11:19 AM
Analyzing Hansen Medical (HNSN) & Quidel Corporation (QDEL)Analyzing Hansen Medical (HNSN) & Quidel Corporation (QDEL)
www.americanbankingnews.com - October 2 at 8:14 PM
Quidel (QDEL) Announces Early Termination of HSR Waiting Period ... - StreetInsider.comQuidel (QDEL) Announces Early Termination of HSR Waiting Period ... - StreetInsider.com
www.streetinsider.com - September 30 at 8:39 AM
Insider Selling: Quidel Corporation (QDEL) CEO Sells 12,000 Shares of StockInsider Selling: Quidel Corporation (QDEL) CEO Sells 12,000 Shares of Stock
www.americanbankingnews.com - September 29 at 10:22 PM

SEC Filings

Quidel (NASDAQ:QDEL) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Quidel (NASDAQ:QDEL) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Quidel (NASDAQ QDEL) Stock Chart for Thursday, December, 14, 2017

Loading chart…

This page was last updated on 12/14/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.